SCHEMBL8766967

SCHEMBL8766967

O=C(c1ccccc1)C1(c2ccccc2)N=N1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
F2 P00734 1/20 0.43
CES1 P23141 5/20 0.42
CES2 O00748 4/20 0.42
TSHR P16473 2/20 0.42
ALDH1A1 P00352 2/20 0.42
DAO P14920 1/20 0.42
NAPRT Q6XQN6 1/20 0.42
TDP1 Q9NUW8 4/20 0.39
MAPT P10636 3/20 0.39
CYP3A4 P08684 2/20 0.39
CA2 P00918 2/20 0.39
CA4 P22748 2/20 0.39
HSD17B10 Q99714 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA9 Q16790 2/20 0.39
POLB P06746 1/20 0.39
PARP1 P09874 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5496475 0.70 LMNA (0.43) LMNAF2CES1CES2TSHR
SCHEMBL1694005 0.68 ALDH1A1 (0.46) LMNACES1CES2TSHRALDH1A1
SCHEMBL31469563 0.67 LMNA (0.44) LMNAF2CES1CES2TSHR
SCHEMBL31291528 0.67 AKR1C1 (0.42) LMNAF2CES1CES2TSHR
SCHEMBL8463882 0.65 CES1 (0.48) LMNAF2CES1CES2TSHR
SCHEMBL2417682 0.65 CES1 (0.48) LMNAF2CES1CES2TSHR
SCHEMBL6698945 0.64 CES1 (0.46) LMNAF2CES1CES2TSHR
SCHEMBL9767764 0.64 CES1 (0.46) LMNAF2CES1CES2TSHR
SCHEMBL8214399 0.63
SCHEMBL4964244 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0788478-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-08-13 EP disclosed
WO-1996013484-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1996-05-09 WO disclosed